Designs Amendment (Advisory Council on Intellectual Property Response) Bill 2020 The designs system in Australia, regulated by the Designs Act 2003, protects the visual features of a product and a registered design can include the shape, configuration, pattern and ornamentation which, when applied to a product, give it a unique appearance. In recent years, a variety of concerns were raised …
Australia’s Full Federal Court Considers Infringement of Swiss-Style Claims
Mylan Health Pty Ltd V Sun Pharma Anz Pty Ltd [2020] FCAFC 116 Mylan v Sun Pharma is the latest word from the Full Federal Court on the infringement of Swiss-style claims, novelty, inventive step and fair basis. Before the Full Court was three patents relating to fenofibrate, a drug used to treat cholesterol and diabetic retinopathy in patients with …
Opposition Hearings in Social Isolation – The Show Must Go on
Wrays is pleased to advise of its recent success in defending one of its client’s patent applications in opposition proceedings before the Australian Patent Office (Desaln8 Pty ltd v Crisalis International Pty Ltd [2020] APO 30 (24 June 2020)). The opposition hearing was notable because it was held just as COVID-19 lockdown measures were being implemented. The hearing was initially …
Myanmar – Witnessing the Birth of Trade Mark Law
A good Hong Kong colleague said to me recently, “How often do you get to witness the birth of trade mark law in a country? Not just new but original?” Myanmar, previously called Burma, is such a country. Myanmar is the largest country in mainland South-East Asia. It is bordered by Bangladesh, India, China, Laos, Thailand, and coastally, by the Andaman …
Making the Most of Meetings With Your IP Expert
Want to get the most out of your next meeting with an IP professional? In this webinar, Adrian Huber and Bindhu Holavanahalli present some tips on what to think about and how to get organised before your meeting, and also answer some common IP questions that often arise during our initial meetings with clients. The following was recorded live as …
Essentials for your IP Toolkit
As more and more business owners and managers recognise that IP is an asset that needs to be suitably managed and protected, just like any other business asset, we are increasingly advising our clients on ways to adopt a sound IP management framework to help safeguard and maximise business opportunities from IP assets. This invariably necessitates the adoption of various …
Effectively Manage your IP Costs
When cash flow is limited, it is tempting to slash expenditure across the board, including reducing or even ceasing expenditure on intellectual property. But intentionally deciding to jettison IP rights may be misguided and short-sighted. Loss of a business’ IP rights may well be worse for long term business value than losing tangible assets, as tangible assets can be re-purchased. …
The Power of Searching
With record number of filings in Australia as well as further afield, patent searching is becoming more complex and even more critical to businesses big and small. In this webinar, Wrays’ Principal Brendan Peachey is joined by guest presenter Louisa King, Director of Aperture Insight. They discuss the importance of searching, providing tips on where to start, and outline ways …
Wrays’ Life Sciences Team Making an Impact on the World Pharmaceutical Market
Australia is producing impressive results on the world pharmaceutical stage. To date, Australia has developed 13 drugs that have received approval from the United States Food and Drug Administration (FDA). Of these 13, 5 were patented by the services provided by Wrays, including FDA approved drugs from iCeutica and Sarepta. Wrays’ Chairman Gary Cox said “We congratulate our clients iCeutica …
Bayer Prevails Against Norbrook in Australian Patent Opposition to Its Teat Seal Formulation Patent Application
In the latest chapter of the dispute between Bayer New Zealand Limited (Bayer) and Norbrook Laboratories Limited (Norbrook), Bayer has successfully defended an opposition to its Australian patent application for a teat-seal formulation used to prevent mastitis in cows Norbrook opposed Bayer’s patent application on the grounds of lack of clarity, lack of sufficiency, lack of support, lack of utility …